Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Victoria Luchenko

Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma

British Journal of Haematology

Hematology

2010

English

Heat Shock Enhances CMV-IE Promoter-Driven Metabotropic Glutamate Receptor Expression and Toxicity in Transfected Cells

Neuropharmacology

Molecular Neuroscience

Cellular

Pharmacology

2011

English

Related publications

Romidepsin: Evidence for Its Potential Use to Manage Previously Treated Cutaneous T Cell Lymphoma

English

A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial

Hematological Oncology

English

A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma

2012

English

Phase I Study of Romidepsin and Liposomal Doxorubicin in Relapsed or Refractory T-Cell Lymphoma

Hematological Oncology

English

Nodal Peripheral T-Cell Lymphoma With Secondary Granulomatous Cutaneous Involvement

Acta Dermato-Venereologica

Dermatology

Medicine

2004

English

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Clinical Case Reports

Medicine

2018

English

Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas

Hematological Oncology

English

PRELIMINARY RESULTS OF ASTX660, a NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-Cell LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

Hematological Oncology

English

A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Victoria Luchenko

Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma

Heat Shock Enhances CMV-IE Promoter-Driven Metabotropic Glutamate Receptor Expression and Toxicity in Transfected Cells

Related publications

Romidepsin: Evidence for Its Potential Use to Manage Previously Treated Cutaneous T Cell Lymphoma

A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial

A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma

Phase I Study of Romidepsin and Liposomal Doxorubicin in Relapsed or Refractory T-Cell Lymphoma

Nodal Peripheral T-Cell Lymphoma With Secondary Granulomatous Cutaneous Involvement

Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma

Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas

PRELIMINARY RESULTS OF ASTX660, a NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-Cell LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA

A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)